The efficacy of a non-leaching antibacterial central venous
catheter - a prospective, randomized, double-blind study

J 2020

The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study

KŘIKAVA, Ivo, Martin KOLAR, Barbora GARAJOVA, Tomas BALIK, Alena ŠEVČÍKOVÁ et. al.

Základní údaje

Originální název

The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study

Autoři

KŘIKAVA, Ivo (203 Česká republika, domácí), Martin KOLAR (203 Česká republika), Barbora GARAJOVA (203 Česká republika), Tomas BALIK (203 Česká republika), Alena ŠEVČÍKOVÁ (203 Česká republika, domácí), Ingolf ROSCHKE (276 Německo) a Pavel SEVCIK (203 Česká republika, garant)

Vydání

Biomedical Papers, Olomouc: Palacky University, Olomouc, Palacky University, 2020, 1213-8118

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30223 Anaesthesiology

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.245

Kód RIV

RIV/00216224:14110/20:00116005

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.5507/bp.2019.022

UT WoS

000542635800006

Klíčová slova anglicky

antimicrobial; CVC; non-leaching; catheter-related bloodstream infections

Štítky

14110322, 14110616, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 16. 7. 2020 10:42, Mgr. Tereza Miškechová

Anotace

V originále

Background. Antimicrobial coatings of central venous catheters (CVC) have the potential to reduce the risk of infectious complications. The aim of this study was to examine the efficacy of a catheter with a non-leaching antimicrobial coating against catheter colonization and bloodstream infections (BSI). Methods. The study was conducted in two centers using a prospective, randomized, double-blind and controlled design (680 intensive care patients; a protective CVC (Certofix (R) protect) or a standard CVC (Certofix (R)). Primary objectives were the rates of catheter colonization and BSI in the two groups. Other baseline demographics, APACHE II score, insertion site, location of CVC placement (ICU or theatre), indwelling time and length of ICU stay were comparable for both groups. Results. While the rate of catheter colonization between the coated and uncoated CVC (17.4% vs. 18.7%, P=0.7477) and the rate of microbiologically confirmed catheter associated infections were similar (1.4% vs. 1.9%, P=0.7521), the coated CVC showed a significantly lower incidence of BSI (2.0% vs. 6.5%, P=0.0081) and a significantly lower mean incidence of BSI per 1000 catheter days (3.2 vs. 8.3, P=0.0356). Conclusion. The non-leaching antibacterial coating of the protective catheter was effective in reducing the incidence of BSI but not the rate of catheter colonization. However, the incidence of BSI is a better surrogate marker for the risk of developing clinical signs of infection suggesting that use of the non-leaching protective catheter is effective in this regard.

Citovat

KŘIKAVA, Ivo, Martin KOLAR, Barbora GARAJOVA, Tomas BALIK, Alena ŠEVČÍKOVÁ, Ingolf ROSCHKE a Pavel SEVCIK. The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study. Biomedical Papers, Olomouc: Palacky University. Olomouc: Palacky University, 2020, roč. 164, č. 2, s. 154-160. ISSN 1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2019.022.

@article{1670477,
   author = {Křikava, Ivo and Kolar, Martin and Garajova, Barbora and Balik, Tomas and Ševčíková, Alena and Roschke, Ingolf and Sevcik, Pavel},
   article_location = {Olomouc},
   article_number = {2},
   doi = {http://dx.doi.org/10.5507/bp.2019.022},
   keywords = {antimicrobial; CVC; non-leaching; catheter-related bloodstream infections},
   language = {eng},
   issn = {1213-8118},
   journal = {Biomedical Papers, Olomouc: Palacky University},
   title = {The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study},
   url = {https://biomed.papers.upol.cz/pdfs/bio/2020/02/06.pdf},
   volume = {164},
   year = {2020}
}

TY  - JOUR
ID  - 1670477
AU  - Křikava, Ivo - Kolar, Martin - Garajova, Barbora - Balik, Tomas - Ševčíková, Alena - Roschke, Ingolf - Sevcik, Pavel
PY  - 2020
TI  - The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study
JF  - Biomedical Papers, Olomouc: Palacky University
VL  - 164
IS  - 2
SP  - 154-160
EP  - 154-160
PB  - Palacky University
SN  - 12138118
KW  - antimicrobial
KW  - CVC
KW  - non-leaching
KW  - catheter-related bloodstream infections
UR  - https://biomed.papers.upol.cz/pdfs/bio/2020/02/06.pdf
L2  - https://biomed.papers.upol.cz/pdfs/bio/2020/02/06.pdf
N2  - Background. Antimicrobial coatings of central venous catheters (CVC) have the potential to reduce the risk of infectious complications. The aim of this study was to examine the efficacy of a catheter with a non-leaching antimicrobial coating against catheter colonization and bloodstream infections (BSI). Methods. The study was conducted in two centers using a prospective, randomized, double-blind and controlled design (680 intensive care patients; a protective CVC (Certofix (R) protect) or a standard CVC (Certofix (R)). Primary objectives were the rates of catheter colonization and BSI in the two groups. Other baseline demographics, APACHE II score, insertion site, location of CVC placement (ICU or theatre), indwelling time and length of ICU stay were comparable for both groups. Results. While the rate of catheter colonization between the coated and uncoated CVC (17.4% vs. 18.7%, P=0.7477) and the rate of microbiologically confirmed catheter associated infections were similar (1.4% vs. 1.9%, P=0.7521), the coated CVC showed a significantly lower incidence of BSI (2.0% vs. 6.5%, P=0.0081) and a significantly lower mean incidence of BSI per 1000 catheter days (3.2 vs. 8.3, P=0.0356). Conclusion. The non-leaching antibacterial coating of the protective catheter was effective in reducing the incidence of BSI but not the rate of catheter colonization. However, the incidence of BSI is a better surrogate marker for the risk of developing clinical signs of infection suggesting that use of the non-leaching protective catheter is effective in this regard.
ER  -

KŘIKAVA, Ivo, Martin KOLAR, Barbora GARAJOVA, Tomas BALIK, Alena ŠEVČÍKOVÁ, Ingolf ROSCHKE a Pavel SEVCIK. The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study. \textit{Biomedical Papers, Olomouc: Palacky University}. Olomouc: Palacky University, 2020, roč.~164, č.~2, s.~154-160. ISSN~1213-8118. Dostupné z: https://dx.doi.org/10.5507/bp.2019.022.

Podrobný výpis o publikaci